Q6P2E9 (EDC4_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 100.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Enhancer of mRNA-decapping protein 4 Alternative name(s): Autoantigen Ge-1 Autoantigen RCD-8 Human enhancer of decapping large subunit Short name=Hedls | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1401 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | In the process of mRNA degradation, seems to play a role in mRNA decapping. Component of a complex containing DCP2 and DCP1A which functions in decapping of ARE-containing mRNAs. Promotes complex formation between DCP1A and DCP2. Enhances the catalytic activity of DCP2 (in vitro). Ref.7 |
| Subunit structure | Part of a decapping complex consisting of DCP1A, DCP2, EDC3, EDC4 and probably DDX6. Part of a complex consisting of DCP1A, EDC3, EDC4 and DDX6. Part of a complex consisting of DCP1B, EDC3, EDC4 and DDX6. Interacts with DCP2. Ref.7 |
| Subcellular location | |
| Sequence similarities | Belongs to the WD repeat EDC4 family. Contains 4 WD repeats. |
| Sequence caution | The sequence AAA21833.1 differs from that shown. Reason: Frameshift at position 1189. The sequence AAB51444.1 differs from that shown. Reason: Erroneous initiation. The sequence AAH53598.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm Nucleus |
| Coding sequence diversity | Alternative splicing |
| Domain | Coiled coil Repeat WD repeat |
| PTM | Acetylation Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay Traceable author statement. Source: Reactome gene expressionTraceable author statement. Source: Reactome |
| Cellular_component | cytoplasmic mRNA processing body Inferred from direct assay PubMed 20826699. Source: MGI cytosolTraceable author statement. Source: Reactome nucleusInferred from direct assay Ref.1. Source: UniProtKB |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| DCP2 | Q8IU60 | 4 | EBI-1006038,EBI-521577 | |
| EIF2AK2 | P19525 | 2 | EBI-1006038,EBI-640775 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q6P2E9-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q6P2E9-2) The sequence of this isoform differs from the canonical sequence as follows: 1-381: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1401 | 1401 | Enhancer of mRNA-decapping protein 4 | PRO_0000278962 | |||||
Regions | |||||||||
| Repeat | 174 – 214 | 41 | WD 1 | ||||||
| Repeat | 230 – 277 | 48 | WD 2 | ||||||
| Repeat | 295 – 334 | 40 | WD 3 | ||||||
| Repeat | 342 – 393 | 52 | WD 4 | ||||||
| Region | 913 – 934 | 22 | Sufficient for nuclear localization | ||||||
| Coiled coil | 954 – 1025 | 72 | Potential | ||||||
| Compositional bias | 602 – 676 | 75 | Ser-rich | ||||||
Amino acid modifications | |||||||||
| Modified residue | 125 | 1 | N6-acetyllysine Ref.18 | ||||||
| Modified residue | 693 | 1 | Phosphothreonine Ref.10 Ref.17 | ||||||
| Modified residue | 723 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 725 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 729 | 1 | Phosphoserine Ref.12 Ref.14 Ref.16 Ref.17 | ||||||
| Modified residue | 741 | 1 | Phosphoserine Ref.11 Ref.17 | ||||||
| Modified residue | 821 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 844 | 1 | Phosphoserine Ref.9 Ref.15 | ||||||
| Modified residue | 871 | 1 | Phosphoserine Ref.14 Ref.15 | ||||||
| Modified residue | 875 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 879 | 1 | Phosphoserine Ref.15 Ref.16 Ref.17 | ||||||
| Modified residue | 887 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 892 | 1 | Phosphoserine Ref.17 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 381 | 381 | Missing in isoform 2. | VSP_023412 | |||||
Experimental info | |||||||||
| Sequence conflict | 271 – 272 | 2 | ML → IV in AAA21833. Ref.1 | ||||||
| Sequence conflict | 621 | 1 | S → N in AAB51444. Ref.6 | ||||||
| Sequence conflict | 1018 – 1019 | 2 | QL → HW in AAA21833. Ref.1 | ||||||
| Sequence conflict | 1160 – 1161 | 2 | KA → NG in AAA21833. Ref.1 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The immunoreactive region in a novel autoantigen contains a nuclear localization sequence." Bloch D.B., Rabkina D., Quertermous T., Bloch K.D. Clin. Immunol. Immunopathol. 72:380-389(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Trachea. |
| [3] | "The sequence and analysis of duplication-rich human chromosome 16." Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J. Pennacchio L.A.Nature 432:988-994(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Duodenum, Skin and Testis. |
| [6] | "Cytoplasmic detection of a novel protein containing a nuclear localization sequence by human autoantibodies." Garcia-Lozano J.R., Gonzalez-Escribano M.F., Wichmann I., Nunez-Roldan A. Clin. Exp. Immunol. 107:501-506(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 421-1401 (ISOFORMS 1/2), SUBCELLULAR LOCATION. |
| [7] | "Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping." Fenger-Groen M., Fillman C., Norrild B., Lykke-Andersen J. Mol. Cell 20:905-915(2005) [PubMed] [Europe PMC] [Abstract] Cited for: MASS SPECTROMETRY, INTERACTION WITH DCP1A; DCP1B; DCP2; DDX6 AND EDC3, SUBCELLULAR LOCATION, FUNCTION. |
| [8] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [9] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-844, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-741, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [12] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment." Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J. J. Proteome Res. 7:5167-5176(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: T-cell. |
| [14] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729 AND SER-871, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-723; SER-725; THR-821; SER-844; SER-871 AND SER-879, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729 AND SER-879, MASS SPECTROMETRY. |
| [17] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-729; SER-741; SER-875; SER-879 AND SER-892, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [18] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-125, MASS SPECTROMETRY. |
| [19] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [20] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [21] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | L26339 mRNA. Translation: AAA21833.1. Frameshift. AK128582 mRNA. No translation available. AK291049 mRNA. Translation: BAF83738.1. AC040162 Genomic DNA. No translation available. CH471092 Genomic DNA. Translation: EAW83183.1. BC043616 mRNA. Translation: AAH43616.1. BC053598 mRNA. Translation: AAH53598.1. Different initiation. BC064567 mRNA. Translation: AAH64567.1. U17474 mRNA. Translation: AAB51444.1. Different initiation. |
| IPI | IPI00376317. IPI00641449. |
| PIR | I52882. |
| RefSeq | NP_055144.3. NM_014329.4. |
| UniGene | Hs.75682. |
3D structure databases | |
| ProteinModelPortal | Q6P2E9. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-31192N. |
| IntAct | Q6P2E9. 20 interactions. |
| STRING | 9606.ENSP00000351811. |
PTM databases | |
| PhosphoSite | Q6P2E9. |
Polymorphism databases | |
| DMDM | 74758241. |
Proteomic databases | |
| PaxDb | Q6P2E9. |
| PRIDE | Q6P2E9. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000358933; ENSP00000351811; ENSG00000038358. |
| GeneID | 23644. |
| KEGG | hsa:23644. |
| UCSC | uc002eur.3. human. |
Organism-specific databases | |
| CTD | 23644. |
| GeneCards | GC16P067906. |
| HGNC | HGNC:17157. EDC4. |
| HPA | HPA041164. |
| MIM | 606030. gene. |
| neXtProt | NX_Q6P2E9. |
| PharmGKB | PA145148958. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG270061. |
| HOVERGEN | HBG053855. |
| InParanoid | Q6P2E9. |
| KO | K12616. |
| OMA | ESPRNGL. |
| OrthoDB | EOG42JNQK. |
| PhylomeDB | Q6P2E9. |
Enzyme and pathway databases | |
| Reactome | REACT_21257. Metabolism of RNA. REACT_71. Gene Expression. |
Gene expression databases | |
| ArrayExpress | Q6P2E9. |
| Bgee | Q6P2E9. |
| CleanEx | HS_EDC4. |
| Genevestigator | Q6P2E9. |
Family and domain databases | |
| Gene3D | 2.130.10.10. 1 hit. |
| InterPro | IPR015943. WD40/YVTN_repeat-like_dom. IPR001680. WD40_repeat. IPR017986. WD40_repeat_dom. [Graphical view] |
| SMART | SM00320. WD40. 3 hits. [Graphical view] |
| SUPFAM | SSF50978. WD40_like. 1 hit. |
| PROSITE | PS00678. WD_REPEATS_1. False negative. PS50082. WD_REPEATS_2. 1 hit. PS50294. WD_REPEATS_REGION. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 23644. |
| NextBio | 46453. |
| PMAP-CutDB | Q6P2E9. |
| SOURCE | Search... |
Entry information
| Entry name | EDC4_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q6P2E9 Secondary accession number(s): A6NGM1 Q7Z6H7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
